King Pharmaceuticals KG AmTrust Reinsurance legacy business — Total AmTrust Reinsurance PPD
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by King Pharmaceuticals in its filing.
Tagged under the XBRL concept kg:LiabilityforUnpaidClaimsandClaimsAdjustmentExpensePeriodIncreaseDecreaseNetofCommissionChanges.
The official record: King Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about King Pharmaceuticals's amtrust reinsurance legacy business — total amtrust reinsurance ppd.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is King Pharmaceuticals's amtrust reinsurance legacy business — total amtrust reinsurance PPD?
- King Pharmaceuticals (KG) reported amtrust reinsurance legacy business — total amtrust reinsurance PPD of -$551K in Q1 2026.
- What does amtrust reinsurance legacy business — total amtrust reinsurance PPD mean?
- This metric tracks the total prior period development (PPD) within the legacy reinsurance segment, representing adjustments to loss reserves established in previous reporting periods. Positive development indicates that initial loss estimates were higher than current expectations, while negative development suggests reserves were insufficient. Investors use this to evaluate the accuracy of the company's historical actuarial reserving practices.